- Home
- Market News & Reports
- Market News
- News Details
Web Content Viewer
ActionsSaudi Exchange Announces the Listing of “Balsm Alofoq Medical Co.”
Saudi Exchange announces the listing and trading shares of “Balsm Alofoq Medical Co.” on Nomu – Parallel Market on Monday 16/12/2024, with the symbol 9620 and ISIN Code SA165GU4MA16, with +/- 30% daily price fluctuation limits and +/- 10% static price fluctuation limits.
For more information about “Balsm Alofoq Medical Co.”, please (click here) to review the prospectus.
For more information, please visit Nomu – Parallel Market page on our website by (clicking here).
Back to Market NewsRelated News
-
The Saudi Exchange announces that the fluctuation limits for Makkah Construction and Development Co. will be based on a share price of SAR 94.80
Makkah Construction and Development Co. EGM held on Wednesday 2025/01/15 has approved the capital increase via bonus shares. Thus, the fluctuation limits on Thursday 2025/01/16 for Makkah Construction and Development Co. will be based on a share price of SAR 94.80 and the outstanding orders will be canceled. Furthermore, the Securities Depository Center (Edaa) will deposit the addition shares into the investor’s portfolios by Monday 2025/01/20.
16/01/2025 08:28:27 -
The Capital Market Authority approves the capital increase request for Lana Medical Company through the issuance of bonus shares
The CMA has issued its resolution approving Lana Medical Company's request to increase its capital from SAR (36,000,000) to SAR (54,000,000) through issuing (1) bonus share for every (2) existing shares owned by the shareholders who are registered in the shareholders registry at the Security Depository Center as of the closing of the second trading day after the due date which will be determined later by the Company's board, such increase will be paid by transferring an amount of SAR (17,473,710) from “Retained earnings” account and an amount of SAR (526,290) from “Statutory reserve" account to the Company's capital. Consequently, increasing the Company's outstanding shares from (3,600,000) shares to (5,400,000) shares, by an increase of (1,800,000) shares. The extraordinary general assembly shall be held within six months from this approval date and the Company shall satisfy all regulatory requirements and applicable laws.
15/01/2025 20:03:52 -
The Capital Market Authority Announces the Approval on the Registration and the Public Offering of Aqaseem Factory Company for Chemical and Plastic Industry’s Debt Instruments Program
The Capital Market Authority (“CMA”) announces the issuance of its Board resolution dated 15/07/1446 AH corresponding to 15/01/2025 AD approving the application of Aqaseem Factory Company for Chemical and Plastic Industry (“Issuer”) for the registration and public offering of the debt instruments within a program that does not exceed the value of (500) million Riyal. The prospectus will be published within sufficient time prior to the start of the subscription period. The prospectus includes all relevant information that the investor needs to know before making an investment decision, including the financial statements of the issuer and adequate information about its activities and management, in addition to the details of the issuance program mentioned above. A subscription decision without reading the prospectus carefully and fully reviewing its content, may involve high risks. Therefore, investors should carefully read the prospectus which contains detailed information about the issuer, offering and risk factors. Thus, providing potential investors the ability to evaluate the viability of investing in the offering, taking into consideration the associated risks. If the prospectus proves difficult to understand, it is recommended to consult with an authorized financial advisor prior to making any investment decision. The CMA’s approval on the application should not be considered as a recommendation to subscribe in the offering or the debt instruments of the issuer. The CMA's approval on the application merely means that the legal requirements as per the Capital Market Law and its Implementing Regulations have been met. The CMA’s approval on the application shall be valid for (6) months from the CMA Board resolution date. The approval shall be deemed cancelled if the offering and listing of the issuer’s first intended tranche of the debt instruments of the program is not completed within this period.
15/01/2025 19:58:13 -
Saudi Exchange Company Announces the Approval of the Amended Market Making Regulations and the Amended Market Making Procedures.
The Saudi Exchange Company announces the issuance of the Capital Market Authority Board resolution) dated 18/05/1446H corresponding to 20/11/2024G approving the following: • The Amended Market Making Regulations (click here) . In addition, the Saudi Exchange Company announces the issuance of its Board of Directors resolution dated 07/02/1446H corresponding to 11/08/2024G approving the following: • The Amended Market Making Procedures (click here). The amendments to the Market Making Regulations and Procedures aim to regulate the Market Making activity for the Debt Market Instruments, in order to develop the market in alignment with the Financial Sector Development Program’s (FSDP) objectives to develop an effective and diverse Capital Market. It should be noted that the amended Regulations and Procedures shall be effective starting from its publishing date.
15/01/2025 15:38:18 -
The Capital Market Authority approves the capital increase request for Arabian Plastic Industrial Company through the issuance of bonus shares
The CMA has issued its resolution approving Arabian Plastic Industrial Company's request to increase its capital from SAR (50,000,000) to SAR (75,000,000) through issuing (1) bonus share for every (2) existing shares owned by the shareholders who are registered in the shareholders registry at the Security Depository Center as of the closing of the second trading day after the due date which will be determined later by the Company's board, such increase will be paid by transferring an amount of SAR (25,000,000) from “Retained earnings” account to the Company's capital. Consequently, increasing the Company's outstanding shares from (5,000,000) shares to (7,500,000) shares, by an increase of (2,500,000) shares. The extraordinary general assembly shall be held within six months from this approval date and the Company shall satisfy all regulatory requirements and applicable laws.
14/01/2025 18:56:29